Your browser doesn't support javascript.
loading
Aberrant T-cell exhaustion in severe combined immunodeficiency survivors with poor T-cell reconstitution after transplantation.
Labrosse, Roxane; Boufaied, Ines; Bourdin, Benoîte; Gona, Saideep; Randolph, Haley E; Logan, Brent R; Bourbonnais, Sara; Berthe, Chloé; Chan, Wendy; Buckley, Rebecca H; Parrott, Roberta E; Cuvelier, Geoffrey D E; Kapoor, Neena; Chandra, Sharat; Dávila Saldaña, Blachy J; Eissa, Hesham; Goldman, Fred D; Heimall, Jennifer; O'Reilly, Richard; Chaudhury, Sonali; Kolb, Edward A; Shenoy, Shalini; Griffith, Linda M; Pulsipher, Michael; Kohn, Donald B; Notarangelo, Luigi D; Pai, Sung-Yun; Cowan, Morton J; Dvorak, Christopher C; Haddad, Élie; Puck, Jennifer M; Barreiro, Luis B; Decaluwe, Hélène.
Afiliación
  • Labrosse R; Pediatric Immunology and Rheumatology Division, Department of Pediatrics, University of Montreal, Montreal, Quebec, Canada.
  • Boufaied I; Cytokines and Adaptive Immunity Laboratory, Sainte-Justine University Hospital Research Center, Montreal, Quebec, Canada.
  • Bourdin B; Cytokines and Adaptive Immunity Laboratory, Sainte-Justine University Hospital Research Center, Montreal, Quebec, Canada.
  • Gona S; Genetics, Genomics, and Systems Biology, Department of Medicine, Section of Genetic Medicine, University of Chicago, Chicago, Ill.
  • Randolph HE; Genetics, Genomics, and Systems Biology, Department of Medicine, Section of Genetic Medicine, University of Chicago, Chicago, Ill.
  • Logan BR; Division of Biostatistics, Medical College of Wisconsin, Milwaukee, Wis.
  • Bourbonnais S; Cytokines and Adaptive Immunity Laboratory, Sainte-Justine University Hospital Research Center, Montreal, Quebec, Canada.
  • Berthe C; Cytokines and Adaptive Immunity Laboratory, Sainte-Justine University Hospital Research Center, Montreal, Quebec, Canada.
  • Chan W; Division of Allergy, Immunology, and Blood and Marrow Transplantation, Department of Pediatrics, University of California, San Francisco, and UCSF Benioff Children's Hospital, San Francisco, Calif.
  • Buckley RH; Duke University Medical Center, Durham, NC.
  • Parrott RE; Duke University Medical Center, Durham, NC.
  • Cuvelier GDE; Manitoba Blood and Marrow Transplant Program, CancerCare Manitoba, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Kapoor N; Blood and Marrow Transplant Program, Division of Hematology, Oncology, and Blood and Marrow Transplantation, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, Calif.
  • Chandra S; Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, and the Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio.
  • Dávila Saldaña BJ; Division of Blood and Marrow Transplantation, Children's National Hospital, George Washington University School of Medicine and Health Sciences, Washington, DC.
  • Eissa H; Children's Hospital of Colorado, University of Colorado School of Medicine, Aurora, Colo.
  • Goldman FD; Department of Pediatrics, The University of Alabama at Birmingham, Birmingham, Ala.
  • Heimall J; Allergy and Immunology, The Children's Hospital of Philadelphia, Philadelphia, Pa.
  • O'Reilly R; Department of Pediatrics, Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Chaudhury S; Division of Hematology, Oncology, and Stem Cell Transplantation, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Ill.
  • Kolb EA; Nemours Children's Health, Center for Cancer and Blood Disorders, Wilmington, Del.
  • Shenoy S; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Washington University School of Medicine, St Louis, Mo.
  • Griffith LM; Division of Allergy, Immunology, and Transplantation, National Institutes of Health, Bethesda, Md.
  • Pulsipher M; Blood and Marrow Transplant Program, Division of Hematology, Oncology, and Blood and Marrow Transplantation, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, Calif.
  • Kohn DB; Pediatrics, David Geffen School of Medicine at University of California, Los Angeles, Calif.
  • Notarangelo LD; Laboratory of Clinical Immunology and Microbiology, National Institutes of Health, Bethesda, Md.
  • Pai SY; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Md.
  • Cowan MJ; Division of Allergy, Immunology, and Blood and Marrow Transplantation, Department of Pediatrics, University of California, San Francisco, and UCSF Benioff Children's Hospital, San Francisco, Calif.
  • Dvorak CC; Division of Allergy, Immunology, and Blood and Marrow Transplantation, Department of Pediatrics, University of California, San Francisco, and UCSF Benioff Children's Hospital, San Francisco, Calif.
  • Haddad É; Pediatric Immunology and Rheumatology Division, Department of Pediatrics, University of Montreal, Montreal, Quebec, Canada.
  • Puck JM; Division of Allergy, Immunology, and Blood and Marrow Transplantation, Department of Pediatrics, University of California, San Francisco, and UCSF Benioff Children's Hospital, San Francisco, Calif.
  • Barreiro LB; Genetics, Genomics, and Systems Biology, Department of Medicine, Section of Genetic Medicine, University of Chicago, Chicago, Ill.
  • Decaluwe H; Pediatric Immunology and Rheumatology Division, Department of Pediatrics, University of Montreal, Montreal, Quebec, Canada; Cytokines and Adaptive Immunity Laboratory, Sainte-Justine University Hospital Research Center, Montreal, Quebec, Canada. Electronic address: helene.decaluwe@umontreal.ca.
J Allergy Clin Immunol ; 151(1): 260-271, 2023 01.
Article en En | MEDLINE | ID: mdl-35987350
ABSTRACT

BACKGROUND:

Severe combined immunodeficiency (SCID) comprises rare inherited disorders of immunity that require definitive treatment through hematopoietic cell transplantation (HCT) or gene therapy for survival. Despite successes of allogeneic HCT, many SCID patients experience incomplete immune reconstitution, persistent T-cell lymphopenia, and poor long-term outcomes.

OBJECTIVE:

We hypothesized that CD4+ T-cell lymphopenia could be associated with a state of T-cell exhaustion in previously transplanted SCID patients.

METHODS:

We analyzed markers of exhaustion in blood samples from 61 SCID patients at a median of 10.4 years after HCT.

RESULTS:

Compared to post-HCT SCID patients with normal CD4+ T-cell counts, those with poor T-cell reconstitution showed lower frequency of naive CD45RA+/CCR7+ T cells, recent thymic emigrants, and TCR excision circles. They also had a restricted TCR repertoire, increased expression of inhibitory receptors (PD-1, 2B4, CD160, BTLA, CTLA-4), and increased activation markers (HLA-DR, perforin) on their total and naive CD8+ T cells, suggesting T-cell exhaustion and aberrant activation, respectively. The exhaustion score of CD8+ T cells was inversely correlated with CD4+ T-cell count, recent thymic emigrants, TCR excision circles, and TCR diversity. Exhaustion scores were higher among recipients of unconditioned HCT, especially when further in time from HCT. Patients with fewer CD4+ T cells showed a transcriptional signature of exhaustion.

CONCLUSIONS:

Recipients of unconditioned HCT for SCID may develop late post-HCT T-cell exhaustion as a result of diminished production of T-lineage cells. Elevated expression of inhibitory receptors on their T cells may be a biomarker of poor long-term T-cell reconstitution.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunodeficiencia Combinada Grave / Trasplante de Células Madre Hematopoyéticas / Linfopenia Límite: Humans Idioma: En Revista: J Allergy Clin Immunol Año: 2023 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunodeficiencia Combinada Grave / Trasplante de Células Madre Hematopoyéticas / Linfopenia Límite: Humans Idioma: En Revista: J Allergy Clin Immunol Año: 2023 Tipo del documento: Article País de afiliación: Canadá